Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment DOI Creative Commons

Rachel Gravell,

Russell Frood, Anna Littlejohns

et al.

Current Oncology, Journal Year: 2024, Volume and Issue: 31(10), P. 6384 - 6394

Published: Oct. 19, 2024

The study purpose was to develop a machine learning (ML)-based predictive model for event-free survival (EFS) in patients with hepatocellular carcinoma (HCC) undergoing stereotactic ablative radiotherapy (SABR).

Language: Английский

Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment DOI Creative Commons

Rachel Gravell,

Russell Frood, Anna Littlejohns

et al.

Current Oncology, Journal Year: 2024, Volume and Issue: 31(10), P. 6384 - 6394

Published: Oct. 19, 2024

The study purpose was to develop a machine learning (ML)-based predictive model for event-free survival (EFS) in patients with hepatocellular carcinoma (HCC) undergoing stereotactic ablative radiotherapy (SABR).

Language: Английский

Citations

0